EANS-Adhoc: The Management Board of CompuGroup Medical AG decides share buyback

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

09.07.2012

The Management Board of CompuGroup Medical AG, Koblenz, ISIN
DE0005437305 (the company), in accordance with Section 71 (1) 8 of
the German Stock Corporation Act (Aktiengesetz), decided on July 9th,
2012 to make use of the authorization to buy back shares of the
company granted by the shareholders at the annual general meeting on
May 19th 2010. Up to 1,000,000 shares of the company will be
repurchased, corresponding to approximately 1.88 percent of the
company's share capital. The repurchased shares can be used for all
purposes covered by the authorization of the annual general meeting.
Shares will be repurchased exclusively through the XETRA trade of
Deutsche Börse AG (Frankfurt Stock Exchange). The share buyback will
be conducted in compliance with the terms of trade detailed in
Article 5 of Commission Regulation (EC) No. 2273/2003 of December 22,
2003.

The price the company pays per share is not allowed to exceed ten per
cent more or less than the stock market price. The authoritative
stock market price in this context is the non-weighted average price
of the company's share which is determined by the closing auction in
XETRA trading at Frankfurt Stock Exchange on the last five stock
exchange trading days before the day when the shares are acquired. In
addition to this, the shares will not be acquired at prices that are
above the last independently made sale or, if it is higher, the last
independent offer to buy the shares in XETRA trading at Frankfurt
Stock Exchange.

The share buyback will be executed by a credit institute which will
decide on the time of the share's purchase independently and
uninfluenced by the company.

The share buyback will commence from July 9th 2012and will end April
30th , 2015 at the latest. The company's Management Board can decide
to terminate the share buyback early at any time.

Further inquiry note:
Ralf Glass
Vicepresident CEO support
T +49 (0) 160 3630315
E-Mail: ralf.glass@cgm.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: CompuGroup Medical AG
Maria Trost 21
D-56070 Koblenz
phone: +49 (0) 261 8000-0
FAX: +49 (0) 261 8000-1166
mail: investor@cgm.com
WWW: www.cgm.com
sector: Software
ISIN: DE0005437305
indexes:
stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart,
regulated dealing/prime standard: Frankfurt
language: English